Kiri Jefferies-Sewell1, Samuel R Chamberlain2, Naomi A Fineberg1, Keith R Laws3. 1. 1Highly Specialized OCD Service,Hertfordshire, Partnership University National Health Service Foundation Trust,Welwyn Garden City,UK. 2. 3Department of Psychiatry,School of Clinical Medicine,University of Cambridge,Cambridge,UK. 3. 2Department of Psychology,School of Life and Medical Sciences,University of Hertfordshire,Hatfield,UK.
Abstract
Introduction Body dysmorphic disorder (BDD) is a debilitating disorder, characterized by obsessions and compulsions relating specifically to perceived appearance, and which has been newly classified within the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Obsessive-Compulsive and Related Disorders grouping. Until now, little research has been conducted into the cognitive profile of this disorder. METHODS: Participants with BDD (n=12) and participants without BDD (n=16) were tested using a computerized neurocognitive battery investigating attentional set-shifting (Intra/Extra Dimensional Set Shift Task), decision-making (Cambridge Gamble Task), motor response-inhibition (Stop-Signal Reaction Time Task), and affective processing (Affective Go-No Go Task). The groups were matched for age, IQ, and education. RESULTS: In comparison to controls, patients with BDD showed significantly impaired attentional set-shifting, abnormal decision-making, impaired response inhibition, and greater omission and commission errors on the emotional processing task. CONCLUSION: Despite the modest sample size, our results showed that individuals with BDD performed poorly compared to healthy controls on tests of cognitive flexibility, reward and motor impulsivity, and affective processing. Results from separate studies in OCD patients suggest similar cognitive dysfunction. Therefore, these findings are consistent with the reclassification of BDD alongside OCD. These data also hint at additional areas of decision-making abnormalities that might contribute specifically to the psychopathology of BDD.
Introduction Body dysmorphic disorder (BDD) is a debilitating disorder, characterized by obsessions and compulsions relating specifically to perceived appearance, and which has been newly classified within the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Obsessive-Compulsive and Related Disorders grouping. Until now, little research has been conducted into the cognitive profile of this disorder. METHODS:Participants with BDD (n=12) and participants without BDD (n=16) were tested using a computerized neurocognitive battery investigating attentional set-shifting (Intra/Extra Dimensional Set Shift Task), decision-making (Cambridge Gamble Task), motor response-inhibition (Stop-Signal Reaction Time Task), and affective processing (Affective Go-No Go Task). The groups were matched for age, IQ, and education. RESULTS: In comparison to controls, patients with BDD showed significantly impaired attentional set-shifting, abnormal decision-making, impaired response inhibition, and greater omission and commission errors on the emotional processing task. CONCLUSION: Despite the modest sample size, our results showed that individuals with BDD performed poorly compared to healthy controls on tests of cognitive flexibility, reward and motor impulsivity, and affective processing. Results from separate studies in OCDpatients suggest similar cognitive dysfunction. Therefore, these findings are consistent with the reclassification of BDD alongside OCD. These data also hint at additional areas of decision-making abnormalities that might contribute specifically to the psychopathology of BDD.
Authors: K Rubia; S Overmeyer; E Taylor; M Brammer; S C Williams; A Simmons; C Andrew; E T Bullmore Journal: Neurosci Biobehav Rev Date: 2000-01 Impact factor: 8.989
Authors: M Humberstone; G V Sawle; S Clare; J Hykin; R Coxon; R Bowtell; I A Macdonald; P G Morris Journal: Ann Neurol Date: 1997-10 Impact factor: 10.422
Authors: O J Bienvenu; J F Samuels; L A Wuyek; K-Y Liang; Y Wang; M A Grados; B A Cullen; M A Riddle; B D Greenberg; S A Rasmussen; A J Fyer; A Pinto; S L Rauch; D L Pauls; J T McCracken; J Piacentini; D L Murphy; J A Knowles; G Nestadt Journal: Psychol Med Date: 2011-05-13 Impact factor: 7.723
Authors: Lara Menzies; Samuel R Chamberlain; Angela R Laird; Sarah M Thelen; Barbara J Sahakian; Ed T Bullmore Journal: Neurosci Biobehav Rev Date: 2007-10-17 Impact factor: 8.989
Authors: Channing Sofko; Geoffrey Tremont; Jing Ee Tan; Holly Westervelt; David C Ahern; William Menard; Katharine A Phillips Journal: Psychosomatics Date: 2020-01-02 Impact factor: 2.386
Authors: Naomi A Fineberg; Annemieke M Apergis-Schoute; Matilde M Vaghi; Paula Banca; Claire M Gillan; Valerie Voon; Samuel R Chamberlain; Eduardo Cinosi; Jemma Reid; Sonia Shahper; Edward T Bullmore; Barbara J Sahakian; Trevor W Robbins Journal: Int J Neuropsychopharmacol Date: 2018-01-01 Impact factor: 5.176
Authors: Ana Paula Ribeiro; Marcelo Piquet-Pessôa; Carina Félix-da-Silva; Julia Fernandes Eigenheer Mühlbauer; Juliana B de-Salles-Andrade; Leonardo F Fontenelle Journal: BMJ Open Date: 2022-08-26 Impact factor: 3.006